IP Library › Patent Application 18491658
Patent Application
App. No. 18/491,658

Method for Identification of Sensitivity of a Patient to Telomerase Inhibition Therapy

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/491,658
Abstract

The invention provides methods for determining the susceptibility of cancer patients to developing adverse reactions if treated with a telomerase inhibitor drug by measurement of telomere length in appropriate cells of the patient prior to initiation of the telomerase inhibitor treatment.

Claims (2)

1 . A method of monitoring a patient for an adverse event related to telomerase inhibition therapy wherein the method comprises testing a biological sample from the patient for the length or length distribution of telomeres.

2 .- 33 . (canceled)

Assignments (2)
PATENT SECURITY AGREEMENT Recorded Nov 12, 2024
From: GERON CORPORATION
To: BIOPHARMA CREDIT PLC [COLLATERAL AGENT]
Reel/Frame 069341/0832 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2024
From: HARLEY, CALVIN B.; ELIAS, LAURENCE; SMITH, JENNIFER; RATAIN, MARK J.; BENEDETTI, FABIO
To: GERON CORPORATION
Reel/Frame 068960/0798 →